Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2571729rdf:typepubmed:Citationlld:pubmed
pubmed-article:2571729lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C0034838lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C1551074lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C1553024lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C1514893lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C2699488lld:lifeskim
pubmed-article:2571729lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:2571729pubmed:issue10lld:pubmed
pubmed-article:2571729pubmed:dateCreated1989-11-1lld:pubmed
pubmed-article:2571729pubmed:abstractTextThe enantiomers of 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8- amine (1a) were prepared and tested for their actions on central dopamine and serotonin (5-HT) receptors. The dopaminergic effects were shown to reside in the (1)-R enantiomer. It was shown that compound 1a and its (+)-R enantiomer possess potent central 5-HT1A receptor stimulating properties.lld:pubmed
pubmed-article:2571729pubmed:languageenglld:pubmed
pubmed-article:2571729pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:citationSubsetIMlld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2571729pubmed:statusMEDLINElld:pubmed
pubmed-article:2571729pubmed:monthOctlld:pubmed
pubmed-article:2571729pubmed:issn0022-2623lld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:AnderssonBBlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:CarlssonAAlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:NilssonIIlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:ChidesterCClld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:HumberL GLGlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:AsselinA AAAlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:SvenssonAAlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:WikströmHHlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:SvenssonKKlld:pubmed
pubmed-article:2571729pubmed:authorpubmed-author:EkmanAAlld:pubmed
pubmed-article:2571729pubmed:issnTypePrintlld:pubmed
pubmed-article:2571729pubmed:volume32lld:pubmed
pubmed-article:2571729pubmed:ownerNLMlld:pubmed
pubmed-article:2571729pubmed:authorsCompleteYlld:pubmed
pubmed-article:2571729pubmed:pagination2273-6lld:pubmed
pubmed-article:2571729pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:meshHeadingpubmed-meshheading:2571729-...lld:pubmed
pubmed-article:2571729pubmed:year1989lld:pubmed
pubmed-article:2571729pubmed:articleTitleResolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.lld:pubmed
pubmed-article:2571729pubmed:affiliationDepartment of Pharmacology, University of Göteborg, Sweden.lld:pubmed
pubmed-article:2571729pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2571729lld:chembl